doi: 10.1016/s0031-6989(83)80009-5.
Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations in the rat
- PMID: 6856656
- DOI: 10.1016/s0031-6989(83)80009-5
Item in Clipboard
Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations in the rat
Pharmacol Res Commun.
1983 Mar.
Abstract
Subchronic treatment of rats with the antidepressant drug chlorimipramine produced an accumulation of phospholipids (PL) which was particularly evident in lung and to a lesser extent in liver and spleen. The overall increase in PL was mostly sustained by phosphatidylcholine. Both chlorimipramine and its demethylated metabolite were preferentially accumulated by lung reaching levels of about two orders of magnitude higher than those found in plasma. A significant correlation between the percentage increase in phospholipid contents and drug metabolite tissue level was evidentiated.
Similar articles
-
Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations [proceedings].Br J Pharmacol. 1979 Nov;67(3):449P-450P. Br J Pharmacol. 1979. PMID: 497566 Free PMC article. No abstract available.
-
[Phospholipidosis of the rat lung following administrations of chlorimipramine].Arch Ital Anat Embriol. 1981;86(1-2):37-53. Arch Ital Anat Embriol. 1981. PMID: 7316635 Italian. No abstract available.
-
Tissue distribution of chlorimipramine and its demethylated metabolite after a single dose in the rat.Pharmacol Res Commun. 1984 Feb;16(2):207-13. doi: 10.1016/s0031-6989(84)80096-x. Pharmacol Res Commun. 1984. PMID: 6504970
-
Drug-induced phospholipidosis.FEBS Lett. 2006 Oct 9;580(23):5533-40. doi: 10.1016/j.febslet.2006.08.061. Epub 2006 Sep 5. FEBS Lett. 2006. PMID: 16979167 Review.
-
Drug-induced phospholipidosis.Ger Med. 1973 Winter;3(3-4):128-35. Ger Med. 1973. PMID: 4370610 Review. No abstract available.
Cited by
-
Clinical and biochemical investigation of male patients exhibiting membranous cytoplasmic bodies in biopsied kidney tissues; a pitfall in diagnosis of Fabry disease.J Nephropathol. 2015 Jul;4(3):91-6. doi: 10.12860/jnp.2015.17. Epub 2015 Jul 1. J Nephropathol. 2015. PMID: 26312237 Free PMC article.
-
The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant.Lung. 1985;163(6):337-44. doi: 10.1007/BF02713834. Lung. 1985. PMID: 3937951 No abstract available.
-
The induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone.Br J Exp Pathol. 1985 Aug;66(4):391-7. Br J Exp Pathol. 1985. PMID: 2992568 Free PMC article.